tradingkey.logo
搜索

Supernus Pharmaceuticals Inc

SUPN
添加自选
27.620USD
+1.460+5.58%
收盘 11-09 16:00(美东)
1.61B总市值
亏损市盈率 TTM

SUPN 财务数据

通过专为投资者打造的一站式数据看板,全面查看 Supernus Pharmaceuticals Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。
关键财务比率
总市值
1.61B
股息TTM
0.00
市盈率 TTM
-54.11
每股收益TTM
-0.51
营业收入
1.24B
净利润
73.86M
净资产收益率
-2.75%
总资产收益率
-2.04%
Supernus Pharmaceuticals Inc 财报日历
最新发布
10月 29, 2026
每股收益 / 预测值
1.16/0.49
营业收入 / 预测值
356.00M/215.92M

财务报表摘要

单季报
单季报+年报
单季报
年报
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
财务指标
每股收益
245.53%1.16
-350.30%-1.01
81.21%-0.04
-125.88%-0.07
-214.29%-0.80
10.86%0.40
-9467.70%-0.21
1185.30%0.28
338.61%0.70
2475.41%0.36
-99.27%0.00
-95.43%0.02
---0.29
---0.02
--0.31
--0.47
--0.66
----
----
----
营业收入
85.32%356.00M
32.40%219.06M
38.63%207.71M
21.48%211.57M
9.34%192.10M
-1.71%165.45M
4.30%149.82M
5.99%174.16M
14.17%175.69M
24.17%168.32M
-6.58%143.64M
-1.80%164.31M
-13.24%153.88M
-20.28%135.56M
0.82%153.76M
5.20%167.33M
19.46%177.35M
20.32%170.05M
16.48%152.51M
10.79%159.05M
净利润
403.65%137.00M
-359.44%-58.37M
80.61%-2.29M
-126.78%-4.11M
-217.20%-45.12M
12.97%22.50M
-9637.90%-11.83M
1204.51%15.33M
340.97%38.50M
2496.63%19.92M
-99.27%124.00K
-95.39%1.18M
-1013.44%-15.98M
-110.57%-831.00K
-33.84%16.95M
943.45%25.48M
-91.89%1.75M
-66.85%7.87M
349.88%25.62M
-92.06%2.44M
利润率
263.86%38.48%
-295.95%-26.65%
86.01%-1.10%
-122.05%-1.94%
-207.18%-23.49%
14.93%13.60%
-9244.96%-7.89%
1130.78%8.80%
311.06%21.91%
2030.16%11.83%
-99.22%0.09%
-95.30%0.72%
---10.38%
---0.61%
--11.02%
--15.23%
--7.05%
----
----
----
毛利率
13.14%87.64%
-5.41%73.07%
0.16%76.39%
-1.53%78.43%
-1.82%77.47%
-0.21%77.25%
2.20%76.27%
5.87%79.65%
7.41%78.90%
11.21%77.41%
4.00%74.63%
1.79%75.23%
--73.46%
--69.61%
--71.76%
--73.91%
--74.76%
----
----
----
资产负债率
--36.64%
----
----
----
----
----
----
----
----
----
----
-100.00%0.00%
--0.00%
--0.00%
--26.84%
--23.61%
--23.71%
----
----
----
营业收入
85.32%356.00M
32.40%219.06M
38.63%207.71M
21.48%211.57M
9.34%192.10M
-1.71%165.45M
4.30%149.82M
5.99%174.16M
14.17%175.69M
24.17%168.32M
-6.58%143.64M
-1.80%164.31M
-13.24%153.88M
-20.28%135.56M
0.82%153.76M
5.20%167.33M
19.46%177.35M
20.32%170.05M
16.48%152.51M
10.79%159.05M
营业利润
1948.52%190.00M
-125.07%-3.04M
-128.85%-5.94M
-42.03%17.77M
-76.71%9.28M
-33.34%12.14M
38.89%-2.60M
73.46%30.66M
389.42%39.83M
203.57%18.21M
-220.37%-4.25M
-48.52%17.68M
634.34%8.14M
-255.01%-17.59M
34.08%3.53M
16.32%34.33M
-104.66%-1.52M
-55.27%11.35M
-81.51%2.63M
-34.40%29.52M
净利润
403.65%137.00M
-359.44%-58.37M
80.61%-2.29M
-126.78%-4.11M
-217.20%-45.12M
12.97%22.50M
-9637.90%-11.83M
1204.51%15.33M
340.97%38.50M
2496.63%19.92M
-99.27%124.00K
-95.39%1.18M
-1013.44%-15.98M
-110.57%-831.00K
-33.84%16.95M
943.45%25.48M
-91.89%1.75M
-66.85%7.87M
349.88%25.62M
-92.06%2.44M
流动资产
34.70%800.00M
-2.08%723.50M
6.40%731.58M
-6.11%644.18M
-7.20%593.89M
25.02%738.87M
26.32%687.58M
39.13%686.07M
42.43%640.00M
39.54%591.00M
-38.38%544.32M
-32.83%493.11M
-32.31%449.36M
-32.25%423.54M
55.38%883.34M
22.04%734.15M
-0.67%663.89M
-2.21%625.12M
-2.99%568.52M
-4.57%601.59M
流动负债总额
293.49%1.30B
21.31%347.38M
32.71%373.93M
15.65%338.17M
13.42%330.63M
-7.22%286.36M
-10.42%281.77M
0.76%292.40M
1.38%291.51M
22.20%308.66M
-57.00%314.55M
-57.82%290.20M
-60.39%287.53M
-65.66%252.59M
157.08%731.54M
118.14%687.96M
209.31%725.99M
159.50%735.54M
18.17%284.56M
28.67%315.38M
总资产
-6.18%1.33B
3.31%1.43B
11.39%1.50B
6.18%1.45B
5.74%1.42B
5.06%1.38B
3.31%1.35B
7.08%1.37B
4.48%1.34B
1.76%1.32B
-27.22%1.30B
-24.95%1.28B
-24.10%1.29B
-23.71%1.29B
9.29%1.79B
0.79%1.70B
8.88%1.69B
7.75%1.69B
8.76%1.64B
12.30%1.69B
总负债
276.13%1.39B
24.61%396.88M
33.90%423.92M
17.63%390.93M
10.29%370.09M
-11.13%318.50M
-15.56%316.58M
-6.69%332.34M
-10.03%335.55M
-3.97%358.38M
-57.38%374.92M
-56.37%356.16M
-55.62%372.97M
-56.28%373.19M
8.46%879.66M
-6.53%816.30M
12.86%840.33M
8.39%853.54M
7.71%811.07M
15.02%873.30M
总权益
-105.72%-60.00M
-3.07%1.03B
4.47%1.08B
2.51%1.06B
4.22%1.05B
11.12%1.06B
10.93%1.03B
12.39%1.04B
10.41%1.01B
4.08%957.45M
1.87%929.17M
3.98%921.52M
6.96%912.19M
9.33%919.91M
10.10%912.15M
8.62%886.20M
5.22%852.80M
7.11%841.43M
9.81%828.45M
9.53%815.85M
经营净额
255.68%96.00M
-108.22%-4.81M
117.41%66.52M
-55.27%19.86M
-215.22%-61.66M
64.31%58.53M
-20.32%30.60M
-1.23%44.41M
49.18%53.52M
288.75%35.62M
-21.83%38.40M
63.10%44.96M
159.19%35.88M
-126.54%-18.87M
1041.93%49.13M
-43.47%27.56M
436.76%13.84M
53.69%71.12M
-88.12%4.30M
52.70%48.76M
投资净额
-128.74%-14.00M
123.18%7.09M
-151.50%-19.22M
-306.00%-51.31M
163.25%48.71M
37.01%-30.61M
172.29%37.32M
80.85%-12.64M
-322.36%-77.01M
-180.59%-48.59M
-121.53%-51.62M
-35.30%-65.98M
142.12%34.63M
484.57%60.30M
442.61%239.78M
-164.05%-48.77M
-1341.65%-82.23M
80.62%-15.68M
2.04%-69.99M
54.28%76.13M
融资净额
-100.00%0.00
-870.05%-7.20M
142.60%9.12M
44.75%8.53M
585.14%21.07M
-43.61%935.00K
-1462.99%-21.40M
439.38%5.89M
1436.96%3.08M
100.35%1.66M
-98.04%1.57M
-61.40%1.09M
-103.56%-230.00K
-21169.78%-478.92M
463.86%80.17M
102.07%2.83M
387.54%6.46M
-17.32%2.27M
-1080.60%-22.03M
-4555.52%-136.74M

营业收入

业务

报告期:
暂无数据

地区

报告期:
暂无数据

常见问题

Supernus Pharmaceuticals Inc的总收入是多少?

根据Supernus Pharmaceuticals Inc的FY2025财报,总收入达到了1.24B(同比变化661.82M)。

Supernus Pharmaceuticals Inc的流动资产是多少?

根据Supernus Pharmaceuticals Inc的FY2025财报,流动资产为652.00M(同比变化-4.97)。

Supernus Pharmaceuticals Inc的总资产是多少?

根据Supernus Pharmaceuticals Inc的FY2025财报,Supernus Pharmaceuticals Inc的总资产为1.20B(同比变化-12.21)。

Supernus Pharmaceuticals Inc的总负债是多少?

根据Supernus Pharmaceuticals Inc的FY2025财报,Supernus Pharmaceuticals Inc的总负债为1.30B(同比变化290.86)。

Supernus Pharmaceuticals Inc的总权益是多少?

根据Supernus Pharmaceuticals Inc的FY2025财报,Supernus Pharmaceuticals Inc的总权益为-98.00M(同比变化-109.46)。

Supernus Pharmaceuticals Inc的净营业收入是多少?

根据Supernus Pharmaceuticals Inc的FY2025财报,Supernus Pharmaceuticals Inc的净营业收入为314.00M(同比变化271.79)。

Supernus Pharmaceuticals Inc的净投资是多少?

根据Supernus Pharmaceuticals Inc的FY2025财报,Supernus Pharmaceuticals Inc的净投资为-66.00M(同比变化65.24)。

Supernus Pharmaceuticals Inc的净融资是多少?

根据Supernus Pharmaceuticals Inc的FY2025财报,Supernus Pharmaceuticals Inc的净融资为-30.00M(同比变化-346.04)。

Supernus Pharmaceuticals Inc的每股收益(EPS)是多少?

根据Supernus Pharmaceuticals Inc的FY2025财报,每股收益(EPS)为1.68(同比变化25.32)。

Supernus Pharmaceuticals Inc的净利润是多少?

根据Supernus Pharmaceuticals Inc的FY2025财报,净利润为210.00M(同比变化184.30)。

Supernus Pharmaceuticals Inc的净利润率是多少?

根据Supernus Pharmaceuticals Inc的FY2025财报,净利润率为16.95(同比变化51.86)。

Supernus Pharmaceuticals Inc的毛利率是多少?

根据Supernus Pharmaceuticals Inc的FY2025财报,毛利率为84.10(同比变化8.11)。

Supernus Pharmaceuticals Inc的股东权益回报率(ROE)是多少?

根据Supernus Pharmaceuticals Inc的FY2025财报,股东权益回报率(ROE)为-3.68(同比变化-148.70)。

Supernus Pharmaceuticals Inc的资产回报率(ROA)是多少?

根据Supernus Pharmaceuticals Inc的FY2025财报,资产回报率(ROA)为16.69(同比变化198.84)。

Supernus Pharmaceuticals Inc的营业利润是多少?

根据Supernus Pharmaceuticals Inc的FY2025财报,营业利润为314.00M(同比变化271.79)。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有